A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus

NCT01405885 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: INO-3605
BIOLOGICAL: INO-3609
BIOLOGICAL: INO-3401
BIOLOGICAL: INO-3609
BIOLOGICAL: INO-3605 AND INO-3609
BIOLOGICAL: INO-3510
BIOLOGICAL: INO-3609
BIOLOGICAL: INO-3609
BIOLOGICAL: Seasonal Influenza vaccine
BIOLOGICAL: INO-3609

Sponsor

Inovio Pharmaceuticals